Glenmark Pharmaceuticals Limited Goodwill

Glenmark Pharmaceuticals Limited's goodwill stands at $830M as of March 2026. That compares with $700M in the prior-year period — up 17.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Glenmark Pharmaceuticals Limited reported $830M in goodwill versus $700M a year earlier — a 17.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $700M in the prior-year period — up 17.9% year over year. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Glenmark Pharmaceuticals Limited's goodwill evolved across reporting periods, while the comparison chart places GLENMARK.BO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.